Investors’ data
Latest news
- January 9, 2012
THALLION AND LFB COMPLETE PATIENT ENROLLMENT OF PHASE II SHIGATEC TRIAL
- October 24, 2011
BLINDED RESULTS FROM LOW DOSE COHORT OF PHASE II SHIGATEC TRIAL PRESENTED AT IDSA ANNUAL MEETING
- October 11, 2011
THALLION ANNOUNCES 2011 THIRD QUARTER RESULTS
Documentation
Investors Overview
Corporate Office
1375 TransCanada Highway, suite 200
Dorval, Quebec
Canada H9P 2W8
Tel.: 514-940-3600
Fax: 514-940-3620
Email: info@thallion.com